Immunosuppression for corneal transplantation and treatment of graft rejection
- PMID: 2650437
Immunosuppression for corneal transplantation and treatment of graft rejection
Similar articles
-
[Immunosuppression in corneal transplantation].J Fr Ophtalmol. 2003 Jun;26(6):637-47. J Fr Ophtalmol. 2003. PMID: 12910207 Review. French.
-
Management of high-risk corneal grafts.Eye (Lond). 2003 Nov;17(8):996-1002. doi: 10.1038/sj.eye.6700634. Eye (Lond). 2003. PMID: 14631407 Review.
-
The impact of corneal allograft rejection on the long-term outcome of corneal transplantation.Am J Ophthalmol. 2005 Dec;140(6):1112-22. doi: 10.1016/j.ajo.2005.07.024. Am J Ophthalmol. 2005. PMID: 16376660 Review.
-
Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.Exp Eye Res. 1997 Jul;65(1):89-98. doi: 10.1006/exer.1997.0316. Exp Eye Res. 1997. PMID: 9237869
-
[Emphasizing the prevention and treatment of immune rejection after corneal transplantation].Zhonghua Yan Ke Za Zhi. 2006 Jan;42(1):3-5. Zhonghua Yan Ke Za Zhi. 2006. PMID: 16638272 Chinese.
Cited by
-
Randomised controlled trial of corticosteroid regimens in endothelial corneal allograft rejection.Br J Ophthalmol. 1999 Dec;83(12):1348-52. doi: 10.1136/bjo.83.12.1348. Br J Ophthalmol. 1999. PMID: 10574812 Free PMC article. Clinical Trial.